IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer

被引：493

作者：

Neurath, Markus F. ^{[1
]}

Finotto, Susetta ^{[1
]}

机构：

[1] Univ Erlangen Nurnberg, Med Clin 1, D-91054 Erlangen, Germany

来源：

CYTOKINE & GROWTH FACTOR REVIEWS | 2011年 / 22卷 / 02期

关键词：

IL-6; Cytokines; TH17; cells; T cell differentiation; Regulatory and effector T cells; Inflammatory bowel disease; Asthma; Rheumatoid arthritis; Cancer; CHRONIC INTESTINAL INFLAMMATION; CELL-MEDIATED COLITIS; NECROSIS-FACTOR-ALPHA; CD4(+) T-CELLS; INTERLEUKIN-6; IL-6; BOWEL-DISEASE; TGF-BETA; IL-6-DEFICIENT MICE; RHEUMATOID-ARTHRITIS; CUTTING EDGE;

D O I：

10.1016/j.cytogfr.2011.02.003

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

IL-6 activates various cell types carrying the membrane bound IL-6R (classical IL-6 signaling) as well as IL-6R(-) gp130(+) cells via the soluble IL-6R (IL-6 trans-signaling). IL-6 signaling plays a pivotal role in controlling the differentiation and activation of T lymphocytes by inducing the Jak/STAT-3 and the Ras/Erk/C/EBP pathways. In particular, IL-6 modulates the resistance of T cells against apoptosis, induces activation of T helper cells and controls the balance between regulatory T cells and Th17 cells. Importantly, recent findings suggest that blockade of IL-6 signaling is effective in treating experimental models of autoimmune and chronic inflammatory diseases such as inflammatory bowel diseases, diabetes, multiple sclerosis, asthma and rheumatoid arthritis as well as models of inflammation-associated cancer. Thus, anti-IL-6/anti-IL-6R strategies emerge as promising novel approaches for therapy of inflammatory diseases in humans. In this review article, we discuss the latest findings on the role of IL-6 in experimental models of autoimmunity and cancer, as well as clinical perspectives. (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：83 / 89

页数：7

共 113 条

[1]

Andriankaja OM, 2009, J PERIODONTOL, V80, P307, DOI [10.1902/jop.2009.080385, 10.1902/jop.2009.080385 ]

[2] Modulation of diabetes with gonadotropin-releasing hormone antagonists in the nonobese mouse model of autoimmune diabetes [J].

Ansari, MA ;

Dhar, M ;

Spieker, S ;

Bakht, N ;

Rahman, AM ;

Moore, WV ;

Jacobson, JD .

ENDOCRINOLOGY, 2004, 145 (01) :337-342

[3] Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation:: Evidence in Crohn disease and experimental colitis in vivo [J].

Atreya, R ;

Mudter, J ;

Finotto, S ;

Müllberg, J ;

Jostock, T ;

Wirtz, S ;

Schütz, M ;

Bartsch, B ;

Holtmann, M ;

Becker, C ;

Strand, D ;

Czaja, J ;

Schlaak, JF ;

Lehr, HA ;

Autschbach, F ;

Schürmann, G ;

Nishimoto, N ;

Yoshizaki, K ;

Ito, H ;

Kishimoto, T ;

Galle, PR ;

Rose-John, S ;

Neurath, MF .

NATURE MEDICINE, 2000, 6 (05) :583-588

[4] TGF-β suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling [J].

Becker, C ;

Fantini, MC ;

Schramm, C ;

Lehr, HA ;

Wirtz, S ;

Nikolaev, A ;

Burg, J ;

Strand, S ;

Kiesslich, R ;

Huber, S ;

Ito, H ;

Nishimoto, N ;

Yoshizaki, K ;

Nishimoto, N ;

Galle, PR ;

Blessing, M ;

Rose-John, S ;

Neurath, MF .

IMMUNITY, 2004, 21 (04) :491-501

[5] TGF-beta as a T cell regulator in colitis and colon cancer [J].

Becker, C ;

Fantini, MC ;

Neurath, MF .

CYTOKINE & GROWTH FACTOR REVIEWS, 2006, 17 (1-2) :97-106

[6] Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].

Bettelli, E ;

Carrier, YJ ;

Gao, WD ;

Korn, T ;

Strom, TB ;

Oukka, M ;

Weiner, HL ;

Kuchroo, VK .

NATURE, 2006, 441 (7090) :235-238

[7] gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis [J].

Bollrath, Julia ;

Phesse, Toby J. ;

von Burstin, Vivian A. ;

Putoczki, Tracy ;

Bennecke, Moritz ;

Bateman, Trudie ;

Nebelsiek, Tim ;

Lundgren-May, Therese ;

Canli, Oezge ;

Schwitalla, Sarah ;

Matthews, Vance ;

Schmid, Roland M. ;

Kirchner, Thomas ;

Arkan, Melek C. ;

Ernst, Matthias ;

Greten, Florian R. .

CANCER CELL, 2009, 15 (02) :91-102

[8] NOD mice have a severly impaired ability to recruit leukocytes into sites of inflammation [J].

Bouma, G ;

Nikolic, T ;

Coppens, JMC ;

van Helden-Meeuwsen, CG ;

Leenen, PJM ;

Drexhage, HA ;

Sozzani, S ;

Versnel, MA .

EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (01) :225-235

[9]

Brown KA, 2002, AM J GASTROENTEROL, V97, P2603

[10]

CAMPBELL IL, 1994, AM J PATHOL, V145, P157

← 1 2 3 4 5 6 7 8 9 10 →